Global Head of Bioprocess and Pharmaceuticals Development, Boehringer Ingelheim
Now in its fourth year, Global Engage is pleased to announce the 4th Biologics & Biosimilars Conference to be held in Berlin on 5th and 6th of March, 2018.
Building on the success of the 2017 conference, this conference will provide in depth studies of antibody therapeutics, biotherapeutic development and biologics for immunotherapy, including oncology and treatment of autoimmune disease and an expanded session on Antibody-Drug Conjugates, as well as a session examining recent clinical and regulatory developments in biosimilars. With over 60 presenters expected to attend and several planned panel discussions on topics including the impact of bispecific antibodies on oncology, developing antibody therapeutics, reviewing antibody-drug conjugate progress, and the current market landscape for biosimilars, this interactive meeting will provide the opportunity to take home cutting edge research, strategies and case study examples and to forge connections with other experts in this field.
A selection of our speakers from 2017 include:
Head of Discovery, Large Molecule Research, Roche Pharma Research and Early Development, Roche Innovation Center Penzberg
200+ senior level attendees
60+ expert speakers
45+ individual presentations plus panel discussions/roundtable
Networking opportunities and 1-2-1 partnership meetings